MDxHealth S.A.

NASDAQ: MDXH · Real-Time Price · USD
2.89
0.05 (1.76%)
At close: Aug 15, 2025, 9:57 AM

MDxHealth S.A. Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
26.61M 24.29M 24.74M 23.32M 22.16M 19.83M 19.4M 19.35M 16.75M 14.7M 12.89M 11.15M 6.9M 6.11M 6.01M 5.5M 5.67M 5.06M
Cost of Revenue
9.04M 8.79M 9.22M 9.04M 8.87M 8.9M 7.85M 6.8M 6.75M 5.99M 5.67M 4.93M 3.97M 3.26M 3.38M 2.93M 2.83M 2.68M
Gross Profit
17.57M 15.5M 15.52M 14.28M 13.29M 10.94M 11.54M 12.55M 9.99M 8.71M 7.22M 6.22M 2.93M 2.84M 2.63M 2.56M 2.84M 2.38M
Operating Income
-1.92M -4.59M -4.61M -6.09M -7.42M -6.61M -6.5M -4.56M -7.74M -8.72M -8.95M -11.93M -9.17M -7.85M -7.25M -7.15M -6.68M -5.76M
Interest Income
n/a 692K n/a 197K 222K 1.37M n/a 564K 1.39M n/a 39K 59K 27K n/a n/a 1K n/a n/a
Pretax Income
n/a -9.07M -6.79M -10.86M -11.53M -8.51M -10.72M -10.04M -10.63M -11.71M -12.31M -13.63M -9.83M -8.27M -8.08M -7.62M -7.12M -6.18M
Net Income
-7.37M -9.21M -6.84M -11.19M -11.53M -8.51M -10.72M -10.04M -10.63M -14.7M -12.44M -13.5M -9.83M -8.69M -8.08M -7.62M -7.12M -6.18M
Selling & General & Admin
19.48M 15.66M 15.57M 16.35M 16.48M 15.39M 13.59M 14.78M 15.34M 14.6M 14.77M 15.87M 10.57M 8.91M -15.47M 8.14M 6.85M 8.13M
Research & Development
n/a 2.5M 2.79M 2.7M 2.9M 2.16M 1.83M 2.35M 2.45M 2.11M 1.8M 2.17M 1.8M 1.78M 2.35M 1.5M 2.82M 1.67M
Other Expenses
n/a 1.93M 1.77M 1.32M 1.33M n/a -1.13M n/a n/a 724K -400K 115K -271K -3K 23.01M 71K -13.61M -13.61M
Operating Expenses
19.48M 20.09M 20.13M 20.37M 20.7M 17.55M 18.04M 17.11M 17.73M 17.43M 16.17M 18.15M 12.1M 10.7M 9.88M 9.71M 9.1M 8.56M
Interest Expense
2.65M 5.18M n/a 4.96M 1.39M 3.28M n/a 6.05M n/a 2.99M 3.28M 1.76M 689K 418K 755K 471K 468.75K 468.75K
Selling & Marketing Expenses
n/a 9.82M 9.7M 10.62M 10.63M 10.03M -21.05M 9.39M 9.6M 9.43M 8.96M 7.77M 5.43M 4.42M -9.98M 4.33M 8.25M 646.75K
Cost & Expenses
28.52M 28.88M 29.35M 29.41M 29.58M 26.45M 25.9M 23.91M 24.49M 23.42M 21.84M 23.08M 16.07M 13.96M 13.26M 12.65M 11.93M 11.24M
Income Tax Expense
n/a 137K 48K 334K n/a n/a 1K n/a n/a 2.99M 128K -129K 1K 418K n/a n/a n/a n/a
Shares Outstanding (Basic)
n/a 48.47M 48.86M 27.97M 27.29M 27.29M 27.29M 27.04M 27.04M 23.42M 12.19M 12.19M 12.19M 12.19M 12.19M 12.19M 11.86M 10.3M
Shares Outstanding (Diluted)
n/a 48.47M 48.86M 47.29M 27.29M 27.29M 27.29M 27.04M 27.04M 23.42M 12.19M 12.19M 12.19M 12.19M 12.19M 12.19M 11.86M 10.3M
EPS (Basic)
-0.15 -0.19 -0.14 -0.4 -0.42 -0.31 -0.39 -0.37 -0.39 -0.63 -1.02 -1.11 -0.81 -0.53 -0.66 -0.63 -0.6 -0.6
EPS (Diluted)
-0.15 -0.19 -0.14 -0.24 -0.42 -0.31 -0.39 -0.37 -0.39 -0.63 -1.02 -1.11 -0.81 -0.71 -0.66 -0.63 -0.6 -0.6
EBITDA
350K -1.65M -2.42M -3.75M -5.62M -4.7M -5.37M -2.7M -8.85M -7.08M -10.51M -10.63M -8.36M -7.07M -6.74M -6.43M -5.93M -5.53M
EBIT
-1.92M -3.9M -4.61M -5.89M -7.42M -6.6M -6.31M -4.56M -10.82M -8.72M -12.54M -11.93M -9.14M -7.85M -7.54M -7.15M -6.68M -5.76M
Depreciation & Amortization
2.27M 2.25M 2.19M 2.15M 1.8M 1.9M 1.13M 1.86M 1.78M 1.64M 2.04M 1.3M 789K 787K 804K 718K 757K 226.25K